The evaluation of approaches to the treatment of myasthenia gravis.

Myasthenia gravis is a relatively rare autoimmune disease with an undetermined aetiology which affects neuromuscular junctions. Currently, the following approaches to the treatment of myasthenia gravis are mainly distinguished: symptomatic treatment with anticholinesterase inhibitors (AChEIs), immun...

Full description

Bibliographic Details
Main Authors: O. I. Kalbus, N. P. Shastun, S. O. Makarov, Yu. V. Bukreyeva, O. V. Somilo
Format: Article
Language:English
Published: SE "Dnipropetrovsk medical academy of Health Ministry of Ukraine" 2019-11-01
Series:Medičnì Perspektivi
Subjects:
Online Access:http://journals.uran.ua/index.php/2307-0404/article/view/181886

Similar Items